Evidence map›Paper›PMID 23926338›Full record

ArticleJournal of virology2013

Lack of B cell dysfunction is associated with functional, gp120-dominant antibody responses in breast milk of simian immunodeficiency virus-infected African green monkeys.

Joshua D Amos, Andrew B Wilks, Genevieve G Fouda, Shannon D Smith, Lisa Colvin, Tatenda Mahlokozera, Carrie Ho, Krista Beck, R Glenn Overman, C Todd DeMarco and 8 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of virology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. B-cell responses to HIV infection.Immunological reviews · 2017
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Joshua D AmosDuke Human Vaccine Institute.
Andrew B Wilks
Genevieve G Fouda
Shannon D Smith
Lisa Colvin
Tatenda Mahlokozera
Carrie Ho
Krista Beck
R Glenn Overman
C Todd DeMarco
Terry L Hodge
Celia C LaBranche
David C Montefiori
Thomas N Denny
Hua-Xin Liao
Georgia D Tomaras
M Anthony Moody
Sallie R Permar
Duke Medical Center · USBeth Israel Deaconess Medical Center · US

Funding

Viral Sequencing CoreU19AI067854 · NIAID · DUKE UNIVERSITY · PI HARRISON, STEPHEN COPLAN · 2006 to 2011
$290.5M
Virus biology scientific research support componentUM1AI100645 · NIAID · DUKE UNIVERSITY · PI MCMICHAEL, ANDREW JAMES · 2012 to 2018
$204.7M
Antibody protection against SIV transmissionR21AI100760 · NIAID · DUKE UNIVERSITY · PI PERMAR, SALLIE R. · 2012 to 2013
$432k
NIAID NIH HHS R21 AI100760NIAID NIH HHS R21AI100760NIAID NIH HHS U19 AI067854NIAID NIH HHS UM1 AI100645PHS HHS HHSN27201100016C
6 · The paper itself

Abstract

The design of an effective vaccine to reduce the incidence of mother-to-child transmission (MTCT) of human immunodeficiency virus (HIV) via breastfeeding will require identification of protective immune responses that block postnatal virus acquisition. Natural hosts of simian immunodeficiency virus (SIV) sustain nonpathogenic infection and rarely transmit the virus to their infants despite high milk virus RNA loads. This is in contrast to HIV-infected women and SIV-infected rhesus macaques (RhMs), nonnatural hosts which exhibit higher rates of postnatal virus transmission. In this study, we compared the systemic and mucosal B cell responses of lactating, SIV-infected African green monkeys (AGMs), a natural host species, to that of SIV-infected RhMs and HIV-infected women. AGMs did not demonstrate hypergammaglobulinemia or accumulate circulating memory B cells during chronic SIV infection. Moreover, the milk of SIV-infected AGMs contained higher proportions of naive B cells than RhMs. Interestingly, AGMs exhibited robust milk and plasma Env binding antibody responses that were one to two logs higher than those in RhMs and humans and demonstrated autologous neutralizing responses in milk at 1 year postinfection. Furthermore, the plasma and milk Env gp120-binding antibody responses were equivalent to or predominant over Env gp140-binding antibody responses in AGMs, in contrast to that in RhMs and humans. The strong gp120-specific, functional antibody responses in the milk of SIV-infected AGMs may contribute to the rarity of postnatal transmission observed in natural SIV hosts.

Indexed as

AnimalsAntibodies, ViralB-LymphocytesChlorocebus aethiopsFemaleHIV InfectionsHumansMacaca mulattaMembrane GlycoproteinsMilk, HumanSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusViral Envelope ProteinsAntibodies, Viralgp120 protein, Simian immunodeficiency virusMembrane GlycoproteinsViral Envelope Proteins

Identifiers

PMID23926338
PMCPMC3807290
OpenAlexW2095882617

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.